NASDAQ: PYPDPolypid Ltd Stock Ownership - Who owns Polypid?
Insider buying vs selling
Have Polypid Ltd insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when PYPD insiders and whales buy or sell their stock.
PYPD Shareholders
What type of owners hold Polypid Ltd stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Aigh Capital Management LLC | 6.80% | 1,065,128 | $4.62M | Institution |
| Rosalind Advisors Inc | 5.87% | 918,668 | $3.99M | Institution |
| Dafna Capital Management LLC | 1.33% | 207,900 | $902.29k | Institution |
| Morgan Stanley | 1.29% | 202,278 | $877.89k | Institution |
| J Goldman Co LP | 1.27% | 199,310 | $865.01k | Institution |
| Symmetry Peak Management LLC | 0.91% | 143,096 | $621.04k | Institution |
| Lumbard Kellner LLC | 0.24% | 38,200 | $165.79k | Institution |
| Xtx Topco Ltd | 0.14% | 21,773 | $94.49k | Institution |
| Goldman Sachs Group Inc | 0.09% | 14,292 | $62.03k | Institution |
| Bnp Paribas Financial Markets | 0.06% | 9,734 | $42.25k | Institution |
PYPD vs Biotech Stocks
Polypid Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.